Eno2 (enolase 2) - Rat Genome Database

Send us a Message

Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Gene: Eno2 (enolase 2) Rattus norvegicus
Symbol: Eno2
Name: enolase 2
RGD ID: 2554
Description: Enables enzyme binding activity; identical protein binding activity; and phosphopyruvate hydratase activity. Involved in several processes, including glucose metabolic process; response to estradiol; and response to xenobiotic stimulus. Located in several cellular components, including growth cone; membrane raft; and synaptic membrane. Part of phosphopyruvate hydratase complex. Biomarker of Parkinsonism; toxic shock syndrome; and visual epilepsy. Human ortholog(s) of this gene implicated in prostate cancer. Orthologous to human ENO2 (enolase 2); PARTICIPATES IN gluconeogenesis pathway; glycolysis pathway; glycolysis/gluconeogenesis pathway; INTERACTS WITH 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane; 2-ethoxyethanol; 2-methoxyethanol.
Type: protein-coding
RefSeq Status: VALIDATED
Previously known as: 2-phospho-D-glycerate hydro-lyase; Enolase 2 gamma neuronal; enolase 2, gamma; enolase 2, gamma, neuronal; gamma-enolase; gamma-enolase-like; LOC100911625; neural enolase; neuron-specific enolase; NSE; RNEN3
RGD Orthologs
Green Monkey
Naked Mole-Rat
Alliance Genes
More Info more info ...
Is Marker For: QTLs:   Coreg2  
Latest Assembly: mRatBN7.2 - mRatBN7.2 Assembly
NCBI Annotation Information: Note: LOC100911625 appears to be a duplicate placement of Eno2 (GeneID: 24334) on Rnor_6.0 (Annot. Release 105) that is absent from Rn_Celera and is not supported by syntenic regions in mouse and human. BLAST analysis of the underlying component AABR07066868.1 against the rat genome shows high sequence identity (88% coverage, 99% identity) with part of NC_005103.4 on which Eno2 is annotated. Annotation of Eno2 at this location on Rnor_6.0 is supported by annotation on Rn_Celera and synteny with mouse and human. [14 Apr 2021]
Rat AssemblyChrPosition (strand)SourceGenome Browsers
GRCr84159,258,371 - 159,267,220 (-)NCBIGRCr8
mRatBN7.24157,572,085 - 157,580,971 (-)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl4157,572,088 - 157,580,980 (-)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx4163,794,317 - 163,803,151 (-)NCBIRnor_SHRUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.04159,577,221 - 159,586,060 (-)NCBIRnor_SHRSPUTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.04158,218,791 - 158,227,643 (-)NCBIRnor_WKYUTH_Rnor_WKY_Bbb_1.0
Rnor_6.04157,285,192 - 157,294,090 (-)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl4157,285,179 - 157,294,047 (-)EnsemblRnor6.0rn6Rnor6.0
Rnor_6.0 Ensembl920,251,521 - 20,260,505 (+)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.04224,302,788 - 224,311,673 (-)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.44160,891,003 - 160,897,723 (-)NCBIRGSC3.4RGSC_v3.4rn4RGSC3.4
RGSC_v3.14161,135,093 - 161,144,004 (-)NCBI
Celera4146,310,173 - 146,318,990 (-)NCBICelera
Cytogenetic Map4q42NCBI
JBrowse: View Region in Genome Browser (JBrowse)

Gene-Chemical Interaction Annotations     Click to see Annotation Detail View
(-)-alpha-phellandrene  (ISO)
1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane  (EXP)
1,1-dichloroethene  (ISO)
1,10-phenanthroline  (ISO)
1,2-dimethylhydrazine  (ISO)
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine  (ISO)
17alpha-ethynylestradiol  (ISO)
17beta-estradiol  (ISO)
17beta-hydroxy-17-methylestra-4,9,11-trien-3-one  (ISO)
2,2',4,4',5,5'-hexachlorobiphenyl  (ISO)
2,2',5,5'-tetrachlorobiphenyl  (ISO)
2,3,7,8-tetrachlorodibenzodioxine  (ISO)
2,4-dibromophenyl 2,4,5-tribromophenyl ether  (ISO)
2-ethoxyethanol  (EXP)
2-hydroxypropanoic acid  (ISO)
2-methoxyethanol  (EXP)
3',5'-cyclic AMP  (EXP)
3,3',5,5'-tetrabromobisphenol A  (ISO)
3,4-dichloroaniline  (ISO)
3-isobutyl-1-methyl-7H-xanthine  (ISO)
3-methyladenine  (EXP)
3-nitropropanoic acid  (EXP)
4,4'-sulfonyldiphenol  (ISO)
5-aza-2'-deoxycytidine  (ISO)
5-azacytidine  (ISO)
6-propyl-2-thiouracil  (EXP)
acrylamide  (ISO)
aflatoxin B1  (ISO)
aldehydo-D-glucose  (ISO)
all-trans-retinoic acid  (ISO)
alpha-phellandrene  (ISO)
aluminium atom  (ISO)
aluminium(0)  (ISO)
amitrole  (EXP)
ammonium chloride  (EXP)
amphetamine  (ISO)
antirheumatic drug  (ISO)
aristolochic acid A  (ISO)
aristolochic acids  (EXP)
arsane  (ISO)
arsenic atom  (ISO)
arsenite(3-)  (ISO)
Azaspiracid  (ISO)
azoxystrobin  (ISO)
benzo[a]pyrene  (EXP,ISO)
benzo[a]pyrene diol epoxide I  (ISO)
bis(2-ethylhexyl) phthalate  (ISO)
bisphenol A  (EXP,ISO)
bisphenol F  (ISO)
bleomycin A5  (ISO)
bortezomib  (ISO)
bucladesine  (ISO)
butanal  (ISO)
cadmium atom  (ISO)
cadmium dichloride  (ISO)
caffeine  (ISO)
cannabidiol  (EXP)
capsaicin  (ISO)
carbon nanotube  (ISO)
cefaloridine  (EXP)
chloroacetaldehyde  (ISO)
chloroquine  (EXP)
chlorpromazine  (EXP)
chromium(6+)  (ISO)
cidofovir anhydrous  (ISO)
cisplatin  (EXP,ISO)
clodronic acid  (ISO)
cobalt atom  (ISO)
cobalt dichloride  (ISO)
cobalt(2+) sulfate  (ISO)
cocaine  (ISO)
cyclosporin A  (ISO)
D-glucose  (ISO)
deguelin  (ISO)
dexamethasone  (ISO)
diethylstilbestrol  (ISO)
dimethylarsinic acid  (EXP)
dinophysistoxin 1  (ISO)
diosmin  (ISO)
dioxygen  (EXP,ISO)
disulfoton  (EXP)
diuron  (ISO)
dorsomorphin  (ISO)
doxorubicin  (ISO)
elemental selenium  (ISO)
endosulfan  (EXP)
entinostat  (ISO)
estriol  (ISO)
estrone  (ISO)
ethanol  (ISO)
ferric oxide  (ISO)
ferroheme b  (ISO)
folic acid  (ISO)
furan  (EXP)
gallic acid  (ISO)
genistein  (ISO)
gentamycin  (EXP)
glucose  (ISO)
heme b  (ISO)
ifosfamide  (ISO)
indometacin  (ISO)
ivermectin  (ISO)
ketamine  (EXP)
leflunomide  (ISO)
Macrosphelide A  (ISO)
maneb  (ISO)
manganese(II) chloride  (EXP,ISO)
melatonin  (ISO)
metformin  (EXP)
methamphetamine  (EXP)
methimazole  (EXP)
methotrexate  (ISO)
methyl methanesulfonate  (ISO)
methylglyoxal  (ISO)
methylseleninic acid  (ISO)
mifepristone  (EXP)
N-acetyl-beta-D-glucosamine  (ISO)
N-acetyl-D-glucosamine  (ISO)
N-nitrosodimethylamine  (ISO)
nickel dichloride  (ISO)
nickel sulfate  (ISO)
niclosamide  (ISO)
Nonylphenol  (ISO)
ochratoxin A  (EXP)
paracetamol  (EXP)
paraquat  (EXP,ISO)
perfluorohexanesulfonic acid  (ISO)
perfluorooctane-1-sulfonic acid  (ISO)
perfluorooctanoic acid  (ISO)
phenylephrine  (EXP)
phenylmercury acetate  (ISO)
picoxystrobin  (ISO)
pirinixic acid  (ISO)
potassium chromate  (ISO)
propanal  (ISO)
rac-lactic acid  (ISO)
raloxifene  (ISO)
resorcinol  (ISO)
resveratrol  (EXP,ISO)
Salidroside  (ISO)
sarin  (EXP)
SB 431542  (ISO)
selenium atom  (ISO)
silicon dioxide  (ISO)
sirolimus  (EXP)
sodium arsenate  (ISO)
sodium arsenite  (EXP,ISO)
sotorasib  (ISO)
streptozocin  (ISO)
succimer  (ISO)
sulfadimethoxine  (EXP)
sunitinib  (ISO)
tebufenpyrad  (ISO)
temozolomide  (ISO)
tetrachloromethane  (ISO)
thapsigargin  (ISO)
thimerosal  (ISO)
thioacetamide  (EXP)
trametinib  (ISO)
tremolite asbestos  (ISO)
trichloroethene  (EXP)
trichostatin A  (ISO)
Tungsten carbide  (ISO)
tunicamycin  (ISO)
urethane  (ISO)
valproic acid  (ISO)
vandetanib  (ISO)
vitamin E  (ISO)
vorinostat  (ISO)
WIN 55212-2  (ISO)
Yessotoxin  (ISO)
zinc dichloride  (ISO)

Gene Ontology Annotations     Click to see Annotation Detail View

Cellular Component

Molecular Function

Molecular Pathway Annotations     Click to see Annotation Detail View

References - curated
# Reference Title Reference Citation
1. Large cell and small cell neuroendocrine bladder carcinoma: immunohistochemical and outcome study in a single institution. Alijo Serrano F, etal., Am J Clin Pathol. 2007 Nov;128(5):733-9.
2. Novel role for gabapentin in neuroprotection of central nervous system in streptozotocine-induced diabetic rats. Baydas G, etal., Acta Pharmacol Sin. 2005 Apr;26(4):417-22.
3. Trajectory analysis of serum biomarker concentrations facilitates outcome prediction after pediatric traumatic and hypoxemic brain injury. Berger RP, etal., Dev Neurosci. 2010;32(5-6):396-405. Epub 2010 Sep 18.
4. Elevation of neuron-specific enolase and S-100beta protein level in experimental acute spinal cord injury. Cao F, etal., J Clin Neurosci. 2008 May;15(5):541-4. Epub 2008 Mar 14.
5. Serum levels of S100B and NSE proteins in Alzheimer's disease patients. Chaves ML, etal., J Neuroinflammation. 2010 Jan 27;7:6.
6. A retrospective immunohistochemical and clinicopathological study of small cell carcinomas of the urinary tract. Chuang CK and Liao SK, Chang Gung Med J. 2003 Jan;26(1):26-33.
7. Proteomic characterization of protein phosphatase 1 complexes in ischemia-reperfusion and ischemic tolerance. Cid C, etal., Proteomics. 2007 Sep;7(17):3207-18.
8. Hippocampal levels of gamma-enolase, C-1-tetrahydrofolate synthase and serotransferrin fluctuate over the estrous cycle in the rat. Diao WF, etal., Neuroscience. 2008 Apr 11;.
9. Zhonghua bing li xue za zhi Chinese journal of pathology Ding HY and Gao LX, Zhonghua Bing Li Xue Za Zhi. 2006 Jan;35(1):13-7.
10. Enolase isoenzymes. III. Chromatographic and immunological characteristics of rat brain enolase. Fletcher L, etal., Biochim Biophys Acta. 1976 Nov 8;452(1):245-52.
11. Neuron-specific enolase: complete structure of rat mRNA, multiple transcriptional start sites, and evidence suggesting post-transcriptional control. Forss-Petter S, etal., J Neurosci Res 1986;16(1):141-56.
12. Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium. Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27.
13. Rat ISS GO annotations from GOA human gene data--August 2006 GOA data from the GO Consortium
14. Increased serum S-100B and neuron specific enolase - Potential markers of early nervous system involvement in essential hypertension. Gonzalez-Quevedo A, etal., Clin Biochem. 2011 Feb;44(2-3):154-9. Epub 2010 Dec 1.
15. Alpha gamma-enolase in the rat: ontogeny and tissue distribution. Jorgensen OS and Centervall G, J Neurochem. 1982 Aug;39(2):537-42.
16. Proteomic characterisation of neuronal sphingolipid-cholesterol microdomains: role in plasminogen activation. Ledesma MD, etal., Brain Res. 2003 Oct 10;987(1):107-16.
17. Measurement of neuron-specific (NSE) and non-neuronal (NNE) isoenzymes of enolase in rat, monkey and human nervous tissue. Marangos PJ, etal., J Neurochem. 1979 Jul;33(1):319-29.
18. Combined large cell neuroendocrine and endometrioid carcinoma of the endometrium. Mulvany NJ and Allen DG, Int J Gynecol Pathol. 2008 Jan;27(1):49-57.
19. Plasminogen binds specifically to alpha-enolase on rat neuronal plasma membrane. Nakajima K, etal., J Neurochem. 1994 Dec;63(6):2048-57.
20. Electronic Transfer of LocusLink and RefSeq Data NCBI rat LocusLink and RefSeq merged data July 26, 2002
21. Cathepsin X cleaves the C-terminal dipeptide of alpha- and gamma-enolase and impairs survival and neuritogenesis of neuronal cells. Obermajer N, etal., Int J Biochem Cell Biol. 2009 Aug-Sep;41(8-9):1685-96. doi: 10.1016/j.biocel.2009.02.019. Epub 2009 Mar 6.
22. Immunophenotype and cytogenetics of mucinous tubular and spindle cell carcinoma of the kidney. Okon K, etal., Pol J Pathol. 2007;58(4):227-33.
23. Oestradiol induced inhibition of neuroendocrine marker expression in Leydig cells of adult rats. Ortega HH, etal., Reprod Domest Anim. 2006 Jun;41(3):204-9.
24. Biochemical brain markers and purinergic parameters in rat CSF after seizure induced by pentylenetetrazol. Oses JP, etal., Brain Res Bull. 2004 Sep 30;64(3):237-42.
25. Nonspecific increase of systemic neuron-specific enolase after trauma: clinical and experimental findings. Pelinka LE, etal., Shock. 2005 Aug;24(2):119-23.
26. KEGG Annotation Import Pipeline Pipeline to import KEGG annotations from KEGG into RGD
27. Response of rat cerebral glycolytic enzymes to hyperammonemic states. Ratnakumari L and Murthy CR, Neurosci Lett. 1993 Oct 14;161(1):37-40.
28. GOA pipeline RGD automated data pipeline
29. Data Import for Chemical-Gene Interactions RGD automated import pipeline for gene-chemical interactions
30. Monochloroacetic acid inhibits liver gluconeogenesis by inactivating glyceraldehyde-3-phosphate dehydrogenase. Sakai A, etal., Chem Res Toxicol. 2005 Feb;18(2):277-82.
31. Molecular cloning and the nucleotide sequence of cDNA for neuron-specific enolase messenger RNA of rat brain. Sakimura K, etal., Proc Natl Acad Sci U S A 1985 Nov;82(21):7453-7.
32. Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Strausberg RL, etal., Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):16899-903. Epub 2002 Dec 11.
33. Tentative Sequence Identification Numbers Tentative Sequence Data IDs. TIGR Gene Index, Rat Data
34. Localization of enolase in synaptic plasma membrane as an alphagamma heterodimer in rat brain. Ueta H, etal., Neurosci Res. 2004 Apr;48(4):379-86.
35. [DNA macroarray analysis of gene expression changes in rat brain after single administration of 2-aminoadamantane compound] Vakhitova IuV, etal., Mol Biol (Mosk). 2005 Mar-Apr;39(2):276-85.
36. Proteomic analysis of striatal proteins in the rat model of L-DOPA-induced dyskinesia. Valastro B, etal., J Neurochem. 2007 Aug;102(4):1395-409. Epub 2007 May 26.
37. [Neuroprotective effects of topiramate and folic acid on young rats with kindling-induced epilepsy] Wang P, etal., Zhongguo Dang Dai Er Ke Za Zhi. 2008 Feb;10(1):65-9.
38. Interleukin-6 inhibits the growth of prostate cancer xenografts in mice by the process of neuroendocrine differentiation. Wang Q, etal., Int J Cancer. 2004 Sep 10;111(4):508-13.
39. Comparative study of primary mammary small cell carcinoma, carcinoma with endocrine features and invasive ductal carcinoma. Yamamoto J, etal., Oncol Rep. 2004 Apr;11(4):825-31.
40. Neoplastic and non-neoplastic cell lines from a malignant peripheral nerve sheath tumour of the cervix of a rat. Yamate J, etal., J Comp Pathol. 2007 Jul;137(1):9-21. Epub 2007 May 29.
41. Zhonghua er ke za zhi. Chinese journal of pediatrics Yang XL, etal., Zhonghua Er Ke Za Zhi. 2006 Aug;44(8):583-6.
42. Elevated S100B and neuron specific enolase levels in patients with migraine-without aura: evidence for neurodegeneration? Yilmaz N, etal., Cell Mol Neurobiol. 2011 May;31(4):579-85. Epub 2011 Feb 4.
43. Zhonghua nan ke xue = National journal of andrology Zhao YC, etal., Zhonghua Nan Ke Xue. 2007 Feb;13(2):157-60.
Additional References at PubMed
PMID:2450052   PMID:2989793   PMID:7753500   PMID:9364238   PMID:9671661   PMID:9758704   PMID:15489334   PMID:16935281   PMID:17634366   PMID:18523310   PMID:18830828   PMID:20458337  
PMID:20592343   PMID:21416483   PMID:22420779   PMID:22528735   PMID:22664934   PMID:23533145   PMID:24042457   PMID:27291422   PMID:28508170   PMID:29728894   PMID:31686426   PMID:32357304  


Comparative Map Data
(Rattus norvegicus - Norway rat)
Rat AssemblyChrPosition (strand)SourceGenome Browsers
GRCr84159,258,371 - 159,267,220 (-)NCBIGRCr8
mRatBN7.24157,572,085 - 157,580,971 (-)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl4157,572,088 - 157,580,980 (-)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx4163,794,317 - 163,803,151 (-)NCBIRnor_SHRUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.04159,577,221 - 159,586,060 (-)NCBIRnor_SHRSPUTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.04158,218,791 - 158,227,643 (-)NCBIRnor_WKYUTH_Rnor_WKY_Bbb_1.0
Rnor_6.04157,285,192 - 157,294,090 (-)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl4157,285,179 - 157,294,047 (-)EnsemblRnor6.0rn6Rnor6.0
Rnor_6.0 Ensembl920,251,521 - 20,260,505 (+)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.04224,302,788 - 224,311,673 (-)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.44160,891,003 - 160,897,723 (-)NCBIRGSC3.4RGSC_v3.4rn4RGSC3.4
RGSC_v3.14161,135,093 - 161,144,004 (-)NCBI
Celera4146,310,173 - 146,318,990 (-)NCBICelera
Cytogenetic Map4q42NCBI
(Homo sapiens - human)
Human AssemblyChrPosition (strand)SourceGenome Browsers
GRCh38126,914,580 - 6,923,697 (+)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl126,913,745 - 6,923,698 (+)EnsemblGRCh38hg38GRCh38
GRCh37127,023,744 - 7,032,860 (+)NCBIGRCh37GRCh37hg19GRCh37
Build 36126,893,875 - 6,903,120 (+)NCBINCBI36Build 36hg18NCBI36
Build 34126,893,874 - 6,903,120NCBI
Celera128,642,227 - 8,651,475 (+)NCBICelera
Cytogenetic Map12p13.31NCBI
HuRef126,879,463 - 6,888,873 (+)NCBIHuRef
CHM1_1127,022,496 - 7,031,732 (+)NCBICHM1_1
T2T-CHM13v2.0126,925,760 - 6,934,876 (+)NCBIT2T-CHM13v2.0
(Mus musculus - house mouse)
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
GRCm396124,737,018 - 124,746,489 (-)NCBIGRCm39GRCm39mm39
GRCm39 Ensembl6124,737,016 - 124,746,636 (-)EnsemblGRCm39 Ensembl
GRCm386124,760,053 - 124,769,673 (-)NCBIGRCm38GRCm38mm10GRCm38
GRCm38.p6 Ensembl6124,760,053 - 124,769,673 (-)EnsemblGRCm38mm10GRCm38
MGSCv376124,710,073 - 124,719,527 (-)NCBIGRCm37MGSCv37mm9NCBIm37
MGSCv366124,725,674 - 124,735,128 (-)NCBIMGSCv36mm8
Celera6126,441,787 - 126,451,238 (-)NCBICelera
Cytogenetic Map6F2NCBI
cM Map659.17NCBI
(Chinchilla lanigera - long-tailed chinchilla)
Chinchilla AssemblyChrPosition (strand)SourceGenome Browsers
ChiLan1.0 EnsemblNW_0049554134,498,625 - 4,506,769 (+)EnsemblChiLan1.0
ChiLan1.0NW_0049554134,498,625 - 4,506,769 (+)NCBIChiLan1.0ChiLan1.0
(Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo AssemblyChrPosition (strand)SourceGenome Browsers
NHGRI_mPanPan1-v21012,477,602 - 12,487,428 (+)NCBINHGRI_mPanPan1-v2
NHGRI_mPanPan11212,474,935 - 12,484,187 (+)NCBINHGRI_mPanPan1
Mhudiblu_PPA_v0127,043,807 - 7,053,178 (+)NCBIMhudiblu_PPA_v0Mhudiblu_PPA_v0panPan3
PanPan1.1126,958,965 - 6,968,342 (+)NCBIpanpan1.1PanPan1.1panPan2
PanPan1.1 Ensembl126,958,960 - 6,968,342 (+)Ensemblpanpan1.1panPan2
(Canis lupus familiaris - dog)
Dog AssemblyChrPosition (strand)SourceGenome Browsers
CanFam3.12738,120,404 - 38,128,543 (-)NCBICanFam3.1CanFam3.1canFam3CanFam3.1
CanFam3.1 Ensembl2738,119,413 - 38,129,182 (-)EnsemblCanFam3.1canFam3CanFam3.1
Dog10K_Boxer_Tasha278,488,257 - 8,496,383 (+)NCBIDog10K_Boxer_Tasha
ROS_Cfam_1.02738,472,946 - 38,481,067 (-)NCBIROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl2738,472,946 - 38,481,347 (-)EnsemblROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.12738,347,347 - 38,355,466 (-)NCBIUMICH_Zoey_3.1
UNSW_CanFamBas_1.02738,388,323 - 38,396,440 (-)NCBIUNSW_CanFamBas_1.0
UU_Cfam_GSD_1.0277,966,986 - 7,975,105 (+)NCBIUU_Cfam_GSD_1.0
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel AssemblyChrPosition (strand)SourceGenome Browsers
HiC_Itri_2NW_024404945102,237,098 - 102,245,902 (-)NCBIHiC_Itri_2
SpeTri2.0 EnsemblNW_004936709904,031 - 913,451 (-)EnsemblSpeTri2.0SpeTri2.0 Ensembl
SpeTri2.0NW_004936709904,647 - 913,445 (-)NCBISpeTri2.0SpeTri2.0SpeTri2.0
(Sus scrofa - pig)
Pig AssemblyChrPosition (strand)SourceGenome Browsers
Sscrofa11.1 Ensembl563,799,930 - 63,809,410 (-)EnsemblSscrofa11.1susScr11Sscrofa11.1
Sscrofa11.1563,799,927 - 63,809,067 (-)NCBISscrofa11.1Sscrofa11.1susScr11Sscrofa11.1
Sscrofa10.2566,236,691 - 66,245,741 (-)NCBISscrofa10.2Sscrofa10.2susScr3
(Chlorocebus sabaeus - green monkey)
Green Monkey AssemblyChrPosition (strand)SourceGenome Browsers
ChlSab1.1116,945,243 - 6,954,959 (+)NCBIChlSab1.1ChlSab1.1chlSab2
ChlSab1.1 Ensembl116,945,413 - 6,957,304 (+)EnsemblChlSab1.1ChlSab1.1 EnsemblchlSab2
Vero_WHO_p1.0NW_0236660631,262,744 - 1,272,484 (-)NCBIVero_WHO_p1.0Vero_WHO_p1.0
(Heterocephalus glaber - naked mole-rat)
Naked Mole-Rat AssemblyChrPosition (strand)SourceGenome Browsers
HetGla_female_1.0 EnsemblNW_0046248603,553,947 - 3,564,294 (+)EnsemblHetGla_female_1.0HetGla_female_1.0 EnsemblhetGla2
HetGla 1.0NW_0046248603,553,936 - 3,561,343 (+)NCBIHetGla_female_1.0HetGla 1.0hetGla2


Variants in Eno2
39 total Variants
miRNA Target Status

Predicted Target Of
Summary Value
Count of predictions:312
Count of miRNA genes:177
Interacting mature miRNAs:202
Transcripts:ENSRNOT00000005535, ENSRNOT00000005601
Prediction methods:Microtar, Miranda, Rnahybrid, Targetscan
Result types:miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.

QTLs in Region (mRatBN7.2)
The following QTLs overlap with this region.    Full Report CSV TAB Printer Gviewer
RGD IDSymbolNameLODP ValueTraitSub TraitChrStartStopSpecies
2316958Gluco58Glucose level QTL 5810blood glucose amount (VT:0000188)blood glucose level (CMO:0000046)411320076180699135Rat
737821Hcar9Hepatocarcinoma resistance QTL 93.7liver integrity trait (VT:0010547)volume of individual liver tumorous lesion (CMO:0001078)4109866907167139601Rat
631674Iddm14Insulin dependent diabetes mellitus QTL 14blood glucose amount (VT:0000188)plasma glucose level (CMO:0000042)464528739157573521Rat
631683Bp116Blood pressure QTL 1160.0001arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)4124303370169303370Rat
737978Pia23Pristane induced arthritis QTL 235.3joint integrity trait (VT:0010548)joint inflammation composite score (CMO:0000919)4131730738167139601Rat
6478718Anxrr34Anxiety related response QTL 340.00896locomotor behavior trait (VT:0001392)amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958)4144639524182687754Rat
6478748Anxrr42Anxiety related response QTL 420.28008locomotor behavior trait (VT:0001392)amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958)4144639524182687754Rat
6478754Anxrr43Anxiety related response QTL 430.14035locomotor behavior trait (VT:0001392)distance moved per unit of time into, out of or within a discrete space in an experimental apparatus (CMO:0001493)4144639524182687754Rat
6478778Anxrr51Anxiety related response QTL 510.25384locomotor behavior trait (VT:0001392)measurement of voluntary locomotion into, out of or within a discrete space in an experimental apparatus (CMO:0000957)4124778595169778595Rat
1298524Oia8Oil induced arthritis QTL 8joint integrity trait (VT:0010548)joint inflammation composite score (CMO:0000919)4138503169173369699Rat
6478693Anxrr32Anxiety related response QTL 320.00092locomotor behavior trait (VT:0001392)measurement of voluntary locomotion into, out of or within a discrete space in an experimental apparatus (CMO:0000957)4144639524182687754Rat
6478700Anxrr33Anxiety related response QTL 330.00896locomotor behavior trait (VT:0001392)amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958)4144639524182687754Rat
631511Pia7Pristane induced arthritis QTL 74.3joint integrity trait (VT:0010548)joint inflammation composite score (CMO:0000919)4131730738167139601Rat
634342Cia24Collagen induced arthritis QTL 244.5joint integrity trait (VT:0010548)joint inflammation composite score (CMO:0000919)4146565735175236377Rat
634347Hcar8Hepatocarcinoma resistance QTL 85.8liver integrity trait (VT:0010547)liver tumorous lesion area to total liver area ratio (CMO:0001075)4123143783168143783Rat
7411558Bw133Body weight QTL 13313.840.001body mass (VT:0001259)body weight gain (CMO:0000420)4125590636170590636Rat
1331738Bp209Blood pressure QTL 2092.979arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)4138503169179293946Rat
10053718Scort25Serum corticosterone level QTL 252.150.0097blood corticosterone amount (VT:0005345)plasma corticosterone level (CMO:0001173)4155561574182687754Rat
1331802Srn5Serum renin concentration QTL 53.045renin activity (VT:0005581)plasma renin activity level (CMO:0000116)4119428175157578333Rat
1358202Gluco11Glucose level QTL 112.40.02adipocyte glucose uptake trait (VT:0004185)absolute change in adipocyte glucose uptake (CMO:0000873)485379421167139601Rat
1549827Scl46Serum cholesterol level QTL 463.5blood cholesterol amount (VT:0000180)serum total cholesterol level (CMO:0000363)4132396220177396220Rat
1581574Eae20Experimental allergic encephalomyelitis QTL 207.8nervous system integrity trait (VT:0010566)percentage of study population developing experimental autoimmune encephalomyelitis during a period of time (CMO:0001047)4153031106158841762Rat
1576316Ept5Estrogen-induced pituitary tumorigenesis QTL 53.8pituitary gland mass (VT:0010496)pituitary gland wet weight (CMO:0000853)483428419177635233Rat
1578674Bmd12Bone mineral density QTL 123.8femur mineral mass (VT:0010011)compact volumetric bone mineral density (CMO:0001730)4135699135180699135Rat
61362Oia2Oil induced arthritis QTL 20.001joint integrity trait (VT:0010548)joint inflammation composite score (CMO:0000919)4138503169173369699Rat
61422Cia13Collagen induced arthritis QTL 134.5joint integrity trait (VT:0010548)joint inflammation composite score (CMO:0000919)4132642577167139601Rat
61446Coreg2Compensatory renal growth QTL 23.5kidney mass (VT:0002707)compensatory renal growth score (CMO:0001894)4148423102157580971Rat
724558Plsm2Polydactyly-luxate syndrome (PLS) morphotypes QTL 20.0003hindlimb integrity trait (VT:0010563)hind foot phalanges count (CMO:0001949)4132422778177422778Rat
2303623Vencon2Ventilatory control QTL 23.8respiration trait (VT:0001943)minute ventilation (CMO:0000132)4135204660180204660Rat
1331759Hrtrt13Heart rate QTL 133.54628heart pumping trait (VT:2000009)heart rate (CMO:0000002)4110275411168266883Rat
724535Cm18Cardiac mass QTL 182.6heart mass (VT:0007028)calculated heart weight (CMO:0000073)4118856416163856416Rat
61451Ciaa4CIA Autoantibody QTL 43.1blood autoantibody amount (VT:0003725)calculated serum anti-rat type 2 collagen autoantibody titer (CMO:0001281)4126395976167139601Rat
12798519Anxrr54Anxiety related response QTL 542.540.05locomotor behavior trait (VT:0001392)distance moved per unit of time into, out of or within a discrete space in an experimental apparatus (CMO:0001493)4114627026159627026Rat
2293659Bmd35Bone mineral density QTL 354.50.0001femur strength trait (VT:0010010)femoral neck ultimate force (CMO:0001703)4137755016181392681Rat
10401796Kidm48Kidney mass QTL 48kidney mass (VT:0002707)both kidneys wet weight (CMO:0000085)4145568712182687754Rat
12798525Anxrr57Anxiety related response QTL 573.210.05locomotor behavior trait (VT:0001392)amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958)4147278504167139601Rat
634335Anxrr16Anxiety related response QTL 167.22locomotor behavior trait (VT:0001392)number of entries into a discrete space in an experimental apparatus (CMO:0000960)493308457167139447Rat
1582237Kidm34Kidney mass QTL 3440.0001kidney mass (VT:0002707)both kidneys wet weight to body weight ratio (CMO:0000340)4148090542168069246Rat

Markers in Region
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.24157,578,205 - 157,578,332 (+)MAPPERmRatBN7.2
mRatBN7.24157,578,205 - 157,578,332 (-)MAPPERmRatBN7.2
Rnor_6.04157,291,311 - 157,291,437NCBIRnor6.0
Rnor_6.0920,254,220 - 20,254,346NCBIRnor6.0
Rnor_5.0919,130,196 - 19,130,322UniSTSRnor5.0
Rnor_5.04224,308,907 - 224,309,033UniSTSRnor5.0
RGSC_v3.44160,896,277 - 160,896,403UniSTSRGSC3.4
RGSC_v3.44160,896,276 - 160,896,403RGDRGSC3.4
RGSC_v3.14161,141,212 - 161,141,339RGD
Celera4146,316,287 - 146,316,413UniSTS
RH 3.4 Map41005.6RGD
RH 3.4 Map41005.6UniSTS
Cytogenetic Map4q42UniSTS
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.24157,578,615 - 157,578,785 (+)MAPPERmRatBN7.2
mRatBN7.24157,578,615 - 157,578,785 (-)MAPPERmRatBN7.2
Rnor_6.04157,291,721 - 157,291,890NCBIRnor6.0
Rnor_6.0920,253,767 - 20,253,936NCBIRnor6.0
Rnor_5.0919,129,743 - 19,129,912UniSTSRnor5.0
Rnor_5.04224,309,317 - 224,309,486UniSTSRnor5.0
RGSC_v3.44160,896,687 - 160,896,856UniSTSRGSC3.4
RGSC_v3.44160,896,686 - 160,896,856RGDRGSC3.4
RGSC_v3.14161,141,622 - 161,141,792RGD
Celera4146,316,697 - 146,316,868UniSTS
RH 3.4 Map41005.6RGD
RH 3.4 Map41005.6UniSTS
Cytogenetic Map4q42UniSTS
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.24157,573,398 - 157,573,521 (+)MAPPERmRatBN7.2
mRatBN7.24157,573,398 - 157,573,521 (-)MAPPERmRatBN7.2
Rnor_6.0920,259,031 - 20,259,151NCBIRnor6.0
Rnor_6.04157,286,506 - 157,286,626NCBIRnor6.0
Rnor_5.0919,135,007 - 19,135,127UniSTSRnor5.0
Rnor_5.04224,304,102 - 224,304,222UniSTSRnor5.0
RGSC_v3.44160,891,472 - 160,891,592UniSTSRGSC3.4
RGSC_v3.44160,891,471 - 160,891,592RGDRGSC3.4
RGSC_v3.14161,136,407 - 161,136,528RGD
Celera4146,311,488 - 146,311,608UniSTS
Cytogenetic Map4q42UniSTS
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.24108,086,268 - 108,086,390 (+)MAPPERmRatBN7.2
Rnor_6.04106,590,076 - 106,590,199NCBIRnor6.0
Rnor_5.04171,308,484 - 171,308,607UniSTSRnor5.0
RGSC_v3.44109,466,351 - 109,466,475RGDRGSC3.4
RGSC_v3.44109,466,352 - 109,466,475UniSTSRGSC3.4
RGSC_v3.14109,710,832 - 109,710,956RGD
Celera497,168,055 - 97,168,178UniSTS
Cytogenetic Map4q42UniSTS
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.24157,573,397 - 157,573,546 (-)MAPPERmRatBN7.2
mRatBN7.24157,573,397 - 157,573,546 (+)MAPPERmRatBN7.2
Rnor_6.0920,259,006 - 20,259,152NCBIRnor6.0
Rnor_6.04157,286,505 - 157,286,651NCBIRnor6.0
Rnor_5.0919,134,982 - 19,135,128UniSTSRnor5.0
Rnor_5.04224,304,101 - 224,304,247UniSTSRnor5.0
RGSC_v3.44160,891,471 - 160,891,617UniSTSRGSC3.4
RGSC_v3.44160,891,470 - 160,891,617RGDRGSC3.4
RGSC_v3.14161,136,406 - 161,136,553RGD
Celera4146,311,487 - 146,311,633UniSTS
RH 3.4 Map41003.0RGD
RH 3.4 Map41003.0UniSTS
Cytogenetic Map4q42UniSTS
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.24157,578,663 - 157,578,781 (-)MAPPERmRatBN7.2
mRatBN7.24157,578,663 - 157,578,781 (+)MAPPERmRatBN7.2
Rnor_6.0920,253,771 - 20,253,888NCBIRnor6.0
Rnor_6.04157,291,769 - 157,291,886NCBIRnor6.0
Rnor_5.0919,129,747 - 19,129,864UniSTSRnor5.0
Rnor_5.04224,309,365 - 224,309,482UniSTSRnor5.0
RGSC_v3.44160,896,735 - 160,896,852UniSTSRGSC3.4
RGSC_v3.44160,895,153 - 160,897,214RGDRGSC3.4
RGSC_v3.14161,141,674 - 161,141,788RGD
Celera4146,316,745 - 146,316,864UniSTS
RH 3.4 Map1735.9RGD
RH 3.4 Map1735.9UniSTS
Cytogenetic Map4q42UniSTS
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.24157,578,182 - 157,578,333 (+)MAPPERmRatBN7.2
mRatBN7.24157,578,182 - 157,578,333 (-)MAPPERmRatBN7.2
Rnor_6.04157,291,288 - 157,291,438NCBIRnor6.0
Rnor_6.0920,254,219 - 20,254,369NCBIRnor6.0
Rnor_5.0919,130,195 - 19,130,345UniSTSRnor5.0
Rnor_5.04224,308,884 - 224,309,034UniSTSRnor5.0
RGSC_v3.44160,896,254 - 160,896,404UniSTSRGSC3.4
RGSC_v3.44160,896,253 - 160,896,404RGDRGSC3.4
RGSC_v3.14161,141,189 - 161,141,340RGD
Celera4146,316,264 - 146,316,414UniSTS
RH 3.4 Map41005.6RGD
RH 3.4 Map41005.6UniSTS
Cytogenetic Map4q42UniSTS
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.24157,578,142 - 157,578,385 (+)MAPPERmRatBN7.2
mRatBN7.24157,578,142 - 157,578,385 (-)MAPPERmRatBN7.2
Rnor_6.0920,254,167 - 20,254,409NCBIRnor6.0
Rnor_6.04157,291,248 - 157,291,490NCBIRnor6.0
Rnor_5.0919,130,143 - 19,130,385UniSTSRnor5.0
Rnor_5.04224,308,844 - 224,309,086UniSTSRnor5.0
RGSC_v3.44160,896,214 - 160,896,456UniSTSRGSC3.4
RGSC_v3.44160,896,213 - 160,896,456RGDRGSC3.4
RGSC_v3.14161,141,149 - 161,141,392RGD
Celera4146,316,224 - 146,316,466UniSTS
RH 2.0 Map4978.5RGD
FHH x ACI Map495.6799RGD
Cytogenetic Map4q42UniSTS
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.24157,572,122 - 157,572,338 (-)MAPPERmRatBN7.2
mRatBN7.24157,572,122 - 157,572,338 (+)MAPPERmRatBN7.2
Rnor_6.04157,285,230 - 157,285,445NCBIRnor6.0
Rnor_6.0920,260,212 - 20,260,427NCBIRnor6.0
Rnor_5.04224,302,826 - 224,303,041UniSTSRnor5.0
Rnor_5.0919,136,188 - 19,136,403UniSTSRnor5.0
RGSC_v3.44160,890,196 - 160,890,411UniSTSRGSC3.4
Celera4146,310,210 - 146,310,425UniSTS
RH 3.4 Map41002.0UniSTS
Cytogenetic Map4q42UniSTS
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.24157,581,316 - 157,581,494 (-)MAPPERmRatBN7.2
mRatBN7.24157,581,316 - 157,581,494 (+)MAPPERmRatBN7.2
Rnor_6.04157,294,418 - 157,294,595NCBIRnor6.0
Rnor_6.0920,251,062 - 20,251,239NCBIRnor6.0
Rnor_5.04224,312,014 - 224,312,191UniSTSRnor5.0
Rnor_5.0919,127,038 - 19,127,215UniSTSRnor5.0
RGSC_v3.44160,899,384 - 160,899,561UniSTSRGSC3.4
Celera4146,319,371 - 146,319,548UniSTS
RH 3.4 Map41010.0UniSTS
Cytogenetic Map4q42UniSTS
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.24157,575,427 - 157,575,610 (+)MAPPERmRatBN7.2
mRatBN7.24157,575,427 - 157,575,610 (-)MAPPERmRatBN7.2
Rnor_6.04157,288,533 - 157,288,715NCBIRnor6.0
Rnor_6.0920,256,942 - 20,257,124NCBIRnor6.0
Rnor_5.0919,132,918 - 19,133,100UniSTSRnor5.0
Rnor_5.04224,306,129 - 224,306,311UniSTSRnor5.0
RGSC_v3.44160,893,499 - 160,893,681UniSTSRGSC3.4
Celera4146,313,515 - 146,313,697UniSTS
Cytogenetic Map4q42UniSTS


RNA-SEQ Expression
High: > 1000 TPM value   Medium: Between 11 and 1000 TPM
Low: Between 0.5 and 10 TPM   Below Cutoff: < 0.5 TPM

alimentary part of gastrointestinal system circulatory system endocrine system hemolymphoid system nervous system renal system reproductive system respiratory system
Low 16
Below cutoff 1 5 3 1 51 3 8 3


RefSeq Acc Id: ENSRNOT00000005535   ⟹   ENSRNOP00000005535
Rat AssemblyChrPosition (strand)Source
mRatBN7.2 Ensembl4157,572,088 - 157,580,980 (-)Ensembl
Rnor_6.0 Ensembl920,251,521 - 20,260,505 (+)Ensembl
RefSeq Acc Id: ENSRNOT00000005601   ⟹   ENSRNOP00000005601
Rat AssemblyChrPosition (strand)Source
mRatBN7.2 Ensembl4157,572,097 - 157,580,556 (-)Ensembl
Rnor_6.0 Ensembl4157,285,179 - 157,294,047 (-)Ensembl
RefSeq Acc Id: ENSRNOT00000098403   ⟹   ENSRNOP00000086529
Rat AssemblyChrPosition (strand)Source
mRatBN7.2 Ensembl4157,572,098 - 157,580,946 (-)Ensembl
RefSeq Acc Id: ENSRNOT00000105206   ⟹   ENSRNOP00000079076
Rat AssemblyChrPosition (strand)Source
mRatBN7.2 Ensembl4157,572,098 - 157,580,946 (-)Ensembl
RefSeq Acc Id: ENSRNOT00000105821   ⟹   ENSRNOP00000093168
Rat AssemblyChrPosition (strand)Source
mRatBN7.2 Ensembl4157,572,098 - 157,580,946 (-)Ensembl
RefSeq Acc Id: NM_139325   ⟹   NP_647541
RefSeq Status: VALIDATED
Rat AssemblyChrPosition (strand)Source
GRCr84159,258,371 - 159,267,220 (-)NCBI
mRatBN7.24157,572,085 - 157,580,936 (-)NCBI
Rnor_6.04157,285,193 - 157,294,037 (-)NCBI
Rnor_5.04224,302,788 - 224,311,673 (-)NCBI
RGSC_v3.44160,891,003 - 160,897,723 (-)RGD
Celera4146,310,173 - 146,318,990 (-)NCBI
RefSeq Acc Id: XM_006237330   ⟹   XP_006237392
Rat AssemblyChrPosition (strand)Source
GRCr84159,258,371 - 159,267,211 (-)NCBI
mRatBN7.24157,572,085 - 157,580,971 (-)NCBI
Rnor_6.04157,285,192 - 157,294,090 (-)NCBI
Rnor_5.04224,302,788 - 224,311,673 (-)NCBI
RefSeq Acc Id: NP_647541   ⟸   NM_139325
- UniProtKB: P07323 (UniProtKB/Swiss-Prot),   A6ILK1 (UniProtKB/TrEMBL),   A0A8L2Q2X9 (UniProtKB/TrEMBL)
- Sequence:
RefSeq Acc Id: XP_006237392   ⟸   XM_006237330
- Peptide Label: isoform X1
- UniProtKB: P07323 (UniProtKB/Swiss-Prot),   A6ILK1 (UniProtKB/TrEMBL),   A0A8L2Q2X9 (UniProtKB/TrEMBL)
- Sequence:
RefSeq Acc Id: ENSRNOP00000005601   ⟸   ENSRNOT00000005601
RefSeq Acc Id: ENSRNOP00000005535   ⟸   ENSRNOT00000005535
RefSeq Acc Id: ENSRNOP00000079076   ⟸   ENSRNOT00000105206
RefSeq Acc Id: ENSRNOP00000086529   ⟸   ENSRNOT00000098403
RefSeq Acc Id: ENSRNOP00000093168   ⟸   ENSRNOT00000105821
Protein Structures
Name Modeler Protein Id AA Range Protein Structure
AF-P07323-F1-model_v2 AlphaFold P07323 1-434 view protein structure


eQTL   View at Phenogen
WGCNA   View at Phenogen
Tissue/Strain Expression   View at Phenogen

RGD ID:13693387
Promoter ID:EPDNEW_R3912
Type:initiation region
SO ACC ID:SO:0000170
Source:EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)
Experiment Methods:Single-end sequencing.
Rat AssemblyChrPosition (strand)Source
Rnor_6.04157,294,023 - 157,294,083EPDNEW

Additional Information

Database Acc Id Source(s)
AGR Gene RGD:2554 AgrOrtholog
BioCyc Gene G2FUF-43071 BioCyc
BioCyc Pathway ANAGLYCOLYSIS-PWY [glycolysis III (from glucose)] BioCyc
  PWY66-399 [gluconeogenesis III] BioCyc
BioCyc Pathway Image ANAGLYCOLYSIS-PWY BioCyc
  PWY66-399 BioCyc
Ensembl Genes ENSRNOG00000013141 Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  ENSRNOG00000048365 Ensembl
  ENSRNOG00055010283 UniProtKB/Swiss-Prot
  ENSRNOG00060032488 UniProtKB/Swiss-Prot
  ENSRNOG00065029257 UniProtKB/Swiss-Prot
Ensembl Transcript ENSRNOT00000005535.7 UniProtKB/TrEMBL
  ENSRNOT00000005601.5 UniProtKB/TrEMBL
  ENSRNOT00000098403.1 UniProtKB/TrEMBL
  ENSRNOT00000105206.1 UniProtKB/TrEMBL
  ENSRNOT00000105821.1 UniProtKB/Swiss-Prot
  ENSRNOT00055017400 UniProtKB/Swiss-Prot
  ENSRNOT00060056278 UniProtKB/Swiss-Prot
  ENSRNOT00065050628 UniProtKB/Swiss-Prot
Gene3D-CATH UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  3.30.390.10 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
InterPro Enolase UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Enolase-like_C_sf UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Enolase-like_N UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Enolase_C UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Enolase_CS UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Enolase_N UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
KEGG Report rno:24334 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  PTHR11902 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
Pfam Enolase_C UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Enolase_N UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
PhenoGen Eno2 PhenoGen
PIRSF Enolase UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
RatGTEx ENSRNOG00000013141 RatGTEx
  ENSRNOG00000048365 RatGTEx
  ENSRNOG00055010283 RatGTEx
  ENSRNOG00060032488 RatGTEx
  ENSRNOG00065029257 RatGTEx
SMART Enolase_C UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Enolase_N UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
Superfamily-SCOP SSF51604 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  SSF54826 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
TIGR TC229025
  A0A8L2Q241_RAT UniProtKB/TrEMBL

Nomenclature History
Date Current Symbol Current Name Previous Symbol Previous Name Description Reference Status
2021-03-09 Eno2  enolase 2  LOC100911625  gamma-enolase-like  Data merged from RGD:6491529 737654 PROVISIONAL
2016-05-04 Eno2  enolase 2  Eno2  enolase 2, gamma, neuronal  Nomenclature updated to reflect human and mouse nomenclature 1299863 APPROVED
2012-07-05 LOC100911625  gamma-enolase-like      Symbol and Name status set to provisional 70820 PROVISIONAL
2008-02-15 Eno2  enolase 2, gamma, neuronal  Eno2  enolase 2, gamma  Nomenclature updated to reflect human and mouse nomenclature 1299863 APPROVED
2004-12-14 Eno2  enolase 2, gamma    enolase 2, gamma   Symbol and Name status set to approved 1299863 APPROVED
2002-06-10 Eno2  enolase 2, gamma       Name updated 70585 PROVISIONAL

RGD Curation Notes
Note Type Note Reference
gene_function catalyzes the interconversion of 2-phosphoglycerate to phosphoenolpyruvate in the glycolytic pathway